Get the Stockscreener App
13.56
2.57%
0.34
After Hours:
13.48
-0.08
-0.59%
Range Cancer Therapeutics Etf Stock (CNCR) Price History
The historical daily chart and data for Range Cancer Therapeutics Etf stock (CNCR), show that the latest closing stock price as of November 22, 2024, is $13.56.
- Range Cancer Therapeutics Etf all-time high stock price is $35.82, occurred on February 08, 2021.
- The lowest Range Cancer Therapeutics Etf stock price recorded was $0.00 on September 06, 2022. Since then, Range Cancer Therapeutics Etf's stock price has risen over to $13.56 now.
- The 52-week high stock price for CNCR is $17.96, representing a 32.45% increase from the current share price, occurred on March 01, 2024.
- The 52-week low stock price for CNCR is $10.49, indicating a -22.64% decrease from the current share price, occurred on November 27, 2023.
- The closing price of Range Cancer Therapeutics Etf (CNCR) stock in the beginning of 2023 was $24.15. The stock closed the year at $13.79, a loss of over -42.90% for the year.
The table below shows more information about CNCR historical price data:
Daily
Weekly
Monthly
7D
30D
60D
YTD
1Y
| Date | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Nov 22, 2024 | $13.70 | $13.28 | $0.4207 | 3,563.0 | +2.57% |
| Nov 21, 2024 | $13.41 | $13.09 | $0.32 | 7,791.0 | -1.49% |
| Nov 20, 2024 | $13.46 | $13.25 | $0.21 | 1,335.0 | -0.07% |
| Nov 19, 2024 | $13.51 | $13.20 | $0.31 | 1,804.0 | +0.60% |
| Nov 18, 2024 | $13.61 | $13.30 | $0.31 | 3,380.0 | -0.30% |
| Nov 15, 2024 | $14.25 | $13.39 | $0.86 | 5,617.0 | -6.05% |
| Nov 14, 2024 | $14.59 | $14.25 | $0.3379 | 3,170.0 | -3.70% |
| Nov 13, 2024 | $15.34 | $14.80 | $0.54 | 1,192.0 | -1.93% |
| Nov 12, 2024 | $15.53 | $15.09 | $0.4386 | 2,291.0 | -4.12% |
| Nov 11, 2024 | $15.94 | $15.59 | $0.35 | 1,694.0 | +0.13% |
| Nov 08, 2024 | $15.72 | $15.56 | $0.16 | 5,508.0 | -0.51% |
| Nov 07, 2024 | $15.91 | $15.73 | $0.18 | 3,314.0 | +1.35% |
| Nov 06, 2024 | $15.73 | $15.46 | $0.269 | 3,098.0 | +2.84% |
| Nov 05, 2024 | $15.16 | $15.01 | $0.1514 | 3,522.0 | +1.34% |
| Nov 04, 2024 | $14.96 | $14.96 | $0.00 | 2,507.0 | +1.49% |
| Nov 01, 2024 | $14.78 | $14.67 | $0.11 | 3,867.0 | +1.10% |
| Oct 31, 2024 | $14.87 | $14.58 | $0.29 | 7,081.0 | -2.15% |
| Oct 30, 2024 | $14.90 | $14.90 | $0.00 | 544.0 | -0.86% |
| Oct 29, 2024 | $15.11 | $14.99 | $0.1151 | 2,273.0 | -1.70% |
| Oct 28, 2024 | $15.34 | $15.05 | $0.29 | 2,468.0 | +4.08% |
| Oct 25, 2024 | $14.85 | $14.69 | $0.16 | 3,914.0 | -1.01% |
Range Cancer Therapeutics Etf Stock (CNCR) Year by Year Price History
In this detailed analysis, we present a comprehensive overview of the price movements of Range Cancer Therapeutics Etf stock over the years. By exploring the year-by-year data, investors can gain valuable insights into the historical performance and volatility of CNCR shares. From significant milestones and fluctuations to notable trends, this in-depth examination of Range Cancer Therapeutics Etf stock price history provides a foundation for understanding how the company's stock has evolved over time.
Range Cancer Therapeutics Etf Stock (CNCR) Price History 2024
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Nov, 2024 | $15.94 | $13.09 | $2.85 | 57,216.0 | -7.00% |
| Oct, 2024 | $15.40 | $14.25 | $1.15 | 79,030.0 | -2.47% |
| Sep, 2024 | $16.27 | $13.94 | $2.33 | 78,951.0 | -0.86% |
| Aug, 2024 | $15.38 | $13.11 | $2.27 | 101,400.0 | -1.44% |
| Jul, 2024 | $15.99 | $13.00 | $2.99 | 183,610.0 | +13.29% |
| Jun, 2024 | $15.05 | $13.41 | $1.64 | 182,975.0 | -6.86% |
| May, 2024 | $15.91 | $14.08 | $1.83 | 186,906.0 | -1.76% |
| Apr, 2024 | $16.59 | $13.77 | $2.82 | 444,906.0 | -11.19% |
| Mar, 2024 | $17.96 | $15.75 | $2.21 | 1,553,505.0 | -3.76% |
| Feb, 2024 | $17.73 | $14.19 | $3.54 | 417,271.0 | +21.96% |
| Jan, 2024 | $14.73 | $13.14 | $1.59 | 125,311.0 | +5.12% |
Range Cancer Therapeutics Etf Stock (CNCR) Price History 2023
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Dec, 2023 | $13.93 | $10.78 | $3.15 | 129,629.0 | +22.40% |
| Nov, 2023 | $11.17 | $9.52 | $1.65 | 46,598.0 | +13.69% |
| Oct, 2023 | $10.84 | $9.22 | $1.62 | 101,046.0 | -11.64% |
| Sep, 2023 | $12.27 | $10.90 | $1.37 | 21,559.0 | -8.86% |
| Aug, 2023 | $12.90 | $11.80 | $1.10 | 45,719.0 | -7.11% |
| Jul, 2023 | $13.44 | $12.33 | $1.11 | 79,608.0 | +0.15% |
| Jun, 2023 | $14.04 | $12.70 | $1.34 | 157,265.0 | -2.78% |
| May, 2023 | $13.90 | $12.80 | $1.10 | 311,701.0 | +5.07% |
| Apr, 2023 | $13.16 | $11.77 | $1.39 | 285,603.0 | +5.50% |
| Mar, 2023 | $13.55 | $11.68 | $1.87 | 80,135.0 | -10.86% |
| Feb, 2023 | $15.18 | $13.27 | $1.91 | 54,051.0 | -9.42% |
| Jan, 2023 | $15.15 | $13.47 | $1.68 | 57,435.0 | +7.68% |
Range Cancer Therapeutics Etf Stock (CNCR) Price History 2022
| Month | High | Low | High - Low | Volume | % Change |
|---|---|---|---|---|---|
| Dec, 2022 | $15.28 | $13.08 | $2.20 | 107,472.0 | -7.51% |
| Nov, 2022 | $15.82 | $14.23 | $1.59 | 56,785.0 | -0.60% |
| Oct, 2022 | $15.43 | $14.05 | $1.38 | 276,875.0 | +2.37% |
| Sep, 2022 | $16.28 | $0.00 | $16.28 | 250,934.0 | -5.51% |
| Aug, 2022 | $18.01 | $15.26 | $2.75 | 89,685.0 | -2.76% |
| Jul, 2022 | $17.05 | $15.16 | $1.89 | 170,725.0 | +4.29% |
| Jun, 2022 | $15.86 | $12.76 | $3.10 | 184,590.0 | +9.85% |
| May, 2022 | $16.09 | $13.08 | $3.01 | 109,573.0 | -10.07% |
| Apr, 2022 | $19.36 | $15.31 | $4.05 | 82,267.0 | -14.02% |
| Mar, 2022 | $18.83 | $16.28 | $2.55 | 134,138.0 | -2.33% |
| Feb, 2022 | $19.76 | $17.20 | $2.56 | 221,486.0 | -4.92% |
| Jan, 2022 | $24.20 | $17.66 | $6.54 | 217,750.0 | -18.55% |
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):